Pharma Industry definition

Pharma Industry means (a) Persons involved in industries that (i) develop, produce, or market drugs or pharmaceuticals licensed for use as medications; or (ii) develop, produce, or market drugs or pharmaceuticals licensed for use as medications as well as over-the-counter medications, and (b) Persons involved in industries related to prescription and over-the-counter medications, neutraceuticals, medical devices, biometric devices, orthodontia, government health agencies, healthcare companies, health publishers, and the advertising agencies supporting the above listed industries.
Sample 1
Pharma Industry means (a) Persons involved in industries that (i) develop, produce, or market drugs or pharmaceuticals licensed for use as medications; or (ii) develop, produce, or market drugs or pharmaceuticals licensed for use as medications as well as over-the-counter medications,
Sample 1Sample 2

Examples of Pharma Industry in a sentence

  • The Outlook of the Pharma Industry remains largely positive over the next few years.

  • Pharma Industry 4.0: Literature review and research opportunities in sustainable pharmaceutical supply chains.

  • Playing a key role in promoting and sustaining development in the vital field of medicines, Indian Pharma Industry boasts of quality producers and many units approved by regulatory authorities in USA and UK.

  • Indian Pharma Industry has been a global leader in Generic drugs.

  • A highly organized sector, the Indian Pharma Industry is estimated to be worth $ 4.5 billion, growing at about 8 to 9 percent annually.

  • The Company being engaged in the business of Pharma Industry, all the operation and management is look after by the Directors of the Company only.

  • Chandurkar, aged 82 years, residing at Mumbai is a Commerce Graduate and has more than 4 decades of experience in the Pharma Industry.

  • As a member of Pharma Industry Finland, Biocodex Oy wants for its part to ensure transparency and openness of the operations and discloses the cooperation information annually.In this memo we present a summary of the methods we have used to create a table of financial benefits.

  • The disclosure follows the codes of the European Federation of Pharmaceutical Industries (EFPIA) and Pharma Industry Finland (PIF).In Finland the members of Pharma Industry Finland are committed to publishing financial information that is related to cooperation with healthcare professionals.

  • The operations of the Company were adversely affected due to change in Government Policies for Pharma Industry.

Related to Pharma Industry

  • Biotechnology means any technological application that uses biological systems, living organisms, or derivatives thereof, to make or modify products or processes for specific use.

  • Modern biotechnology means the application of:

  • Pharmaceutical means a drug intended for use in the diagnosis, cure, mitigation, treatment, therapy, or prevention of disease in humans or animals.

  • Marihuana-infused product means a topical formulation, tincture, beverage, edible substance, or similar product containing marihuana and other ingredients and that is intended for human consumption.

  • Pharmaceutical care means the provision of drug therapy and

  • Radiopharmaceutical means any drug that exhibits spontaneous disintegration of unstable nuclei with the emission of nuclear particles or photons and includes any non-radioactive reagent kit or radionuclide generator that is intended to be used in the preparation of any such substance, but does not include drugs such as carbon-containing compounds or potassium-containing salts that include trace quantities of naturally occurring radionuclides. The term also includes any biological product that is labeled with a radionuclide or intended solely to be labeled with a radionuclide.

  • GCP means the Good Clinical Practices officially published by EMA, FDA and the International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH) that may be in effect from time to time and are applicable to the testing of the Compounds.

  • Pharmaceutical Product shall have the meaning ascribed to such term in Section 3.1(hh).

  • China means the People’s Republic of China, excluding, for purposes of this Agreement, Hong Kong, the Macau Special Administrative Region of the PRC and Taiwan.

  • Radiopharmaceutical quality assurance means, but is not limited to, the performance of appropriate chemical, biological, and physical tests on potential radiopharmaceuticals and the interpretation of the resulting data to determine their suitability for use in humans and animals, including internal test assessment, authentication of product history, and the keeping of proper records.

  • in vitro diagnostic medical device means any medical device which is a reagent, reagent product, calibrator, control material, kit, instrument, apparatus, equipment, software or system, whether used alone or in combination, intended by the manufacturer to be used in vitro for the examination of specimens, including blood and tissue donations, derived from the human body, solely or principally for the purpose of providing information:

  • Elan means Elan Corp and its Affiliates.

  • integrated iron and steel industry means an industry for the manufacture of iron and steel or for the manufacture of steel from iron ore by a process which does not necessarily involve the production of pig iron or basic iron in the production of steel;

  • BG means Bank Guarantee

  • Spectrum means frequencies of electromagnetic spectrum used to provide fixed or mobile communications services as licensed or authorized by the FCC.

  • CIMA means the Cayman Islands Monetary Authority whose contact details are available from www.cima.ky;

  • NPS means nominal pipe size.

  • Cephalometric device means a device intended for the radiographic visualization and measurement of the dimensions of the human head.

  • nanomaterial means a natural, incidental or manufactured material containing particles in an unbound state or as an aggregate or as an agglomerate and where, for 50 % or more of the particles in the number size distribution, one or more external dimensions is in the size range 1-100 nm;

  • medical device means any instrument, apparatus, appliance, software, implant, reagent, material or other article intended by the manufacturer to be used, alone or in combination, for human beings for one or more of the following specific medical purposes:

  • Medical management technique means a practice which is used to control the cost or utilization of health care services or prescription drug use. The term includes, without limitation, the use of step therapy, prior authorization or categorizing drugs and devices based on cost, type or method of administration.

  • Bioassay means the determination of kinds, quantities or concentrations and, in some cases, the locations of radioactive material in the human body, whether by direct measurement, in vivo counting, or by analysis and evaluation of materials excreted or removed from the human body. For purposes of these rules, “radiobioassay” is an equivalent term.

  • Marijuana-infused products means products that contain marijuana or marijuana extracts and are intended for human use. The term "marijuana-infused products" does not include useable marijuana.

  • AMS means the Federal Aviation Administration’s Acquisition Management System.

  • Medical marijuana product means a product that contains cannabinoids that have been extracted from plant material or the resin therefrom by physical or chemical means and is intended for administration to a licensed patient, including but not limited to concentrates, oils, tinctures, edibles, pills, topical forms, gels, creams, and other derivative forms, except that this term does not include live plant forms.

  • IMS means IMS Health Incorporated.